TerrAscend (TSNDF) Cash from Financing Activities (2021 - 2026)

TerrAscend (TSNDF) reported Cash from Financing Activities of -$7.1 million for Q1 2026, down 205.44% year-over-year from $6.8 million in Q1 2025, and down 22.63% quarter-over-quarter from -$5.8 million in Q4 2025.

TerrAscend (TSNDF) Cash from Financing Activities (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Cash from Financing Activities data on file, last reported at -$7.1 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$7.1 million, down 205.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$609000.0 (up 92.97% YoY), and the FY2025 annual result was $4.2 million, up 126.29% from the prior year.
  • Cash from Financing Activities declined to -$7.1 million in Q1 2026 per TSNDF's latest filing, from -$5.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $17.1 million in Q1 2022 and troughed at -$9.6 million in Q1 2024.
  • A 5-year average of -$1.1 million and a median of -$3.2 million in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities sank 1670.81% in 2024, then soared 357.58% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.8 million in 2022, then slumped by 239.22% to -$6.2 million in 2023, then surged by 171.14% to $4.4 million in 2024, then sank by 232.57% to -$5.8 million in 2025, then slipped by 22.63% to -$7.1 million in 2026.
  • Business Quant data shows TSNDF's Cash from Financing Activities at -$7.1 million in Q1 2026, -$5.8 million in Q4 2025, and $9.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 TerrAscend - - 34.60 Mn -7.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.13 Mn
Mar 31, 2026 -7.13 Mn
Dec 31, 2025 -5.82 Mn
Dec 31, 2025 -5.82 Mn
Sep 30, 2025 9.72 Mn
Sep 30, 2025 9.72 Mn
Jun 30, 2025 2.62 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 -2.34 Mn
Mar 31, 2025 -2.34 Mn
Dec 31, 2024 4.39 Mn
Dec 31, 2024 4.39 Mn
Sep 30, 2024 -3.77 Mn
Sep 30, 2024 -3.77 Mn
Jun 30, 2024 -6.94 Mn
Jun 30, 2024 -6.94 Mn
Mar 31, 2024 -9.60 Mn
Mar 31, 2024 -9.60 Mn
Dec 31, 2023 -6.17 Mn
Dec 31, 2023 -6.17 Mn